Cargando…
Osthole inhibits triple negative breast cancer cells by suppressing STAT3
BACKGROUND: Triple-negative breast cancer (TNBC) is an aggressive subgroup of human breast cancer. Patients with TNBC have poor clinical outcome as they are non-responsive to current targeted therapies. There is an urgent need to identify new therapeutic targets and develop more effective treatment...
Autores principales: | Dai, Xuanxuan, Yin, Changtian, Zhang, Yi, Guo, Guilong, Zhao, Chengguang, Wang, Ouchen, Xiang, Youqun, Zhang, Xiaohua, Liang, Guang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303899/ https://www.ncbi.nlm.nih.gov/pubmed/30577812 http://dx.doi.org/10.1186/s13046-018-0992-z |
Ejemplares similares
-
Alantolactone promotes ER stress‐mediated apoptosis by inhibition of TrxR1 in triple‐negative breast cancer cell lines and in a mouse model
por: Yin, Changtian, et al.
Publicado: (2019) -
Acetyl-cinobufagin suppresses triple-negative breast cancer progression by inhibiting the STAT3 pathway
por: Qi, Yufeng, et al.
Publicado: (2023) -
Rhein sensitizes human pancreatic cancer cells to EGFR inhibitors by inhibiting STAT3 pathway
por: Yang, Lehe, et al.
Publicado: (2019) -
Rhein shows potent efficacy against non-small-cell lung cancer through inhibiting the STAT3 pathway
por: Yang, Lehe, et al.
Publicado: (2019) -
L61H46 shows potent efficacy against human pancreatic cancer through inhibiting STAT3 pathway
por: Bai, Encheng, et al.
Publicado: (2018)